amikacin has been researched along with Cronobacter Infections in 133 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (47.37) | 18.7374 |
| 1990's | 15 (11.28) | 18.2507 |
| 2000's | 17 (12.78) | 29.6817 |
| 2010's | 34 (25.56) | 24.3611 |
| 2020's | 4 (3.01) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Castanheira, M; Deshpande, LM; Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY | 1 |
| Chen, Y; Feng, H; Hu, H; Jiang, Y; Qu, T; Shen, P; Wang, H; Yang, Q; Yu, M; Zhang, S; Zhang, Y | 1 |
| Hsueh, PR; Jean, SS | 1 |
| Essack, SY; Feldman, C; Maningi, NE; Mbelle, N; Modipane, L; Osei Sekyere, J | 1 |
| Fu, Y; Guo, Y; Li, C; Wang, Y; Yu, L; Zhang, J; Zhang, X; Zhao, J; Zhao, Y | 1 |
| Giacometti, F; Mondo, E; Piva, S; Rinnovati, R; Savini, F; Serraino, A; Spadari, A | 1 |
| Amadori, F; Bardellini, E; Foresti, I; Majorana, A; Schumacher, RF | 1 |
| Bulitta, JB; Klee, BO; Zavascki, AP | 1 |
| Doi, T; Hirota, K; Imanishi, K; Nakakura, I; Nakamori, S; Ogawa, Y; Sakakura, K; Sako, R; Shimatani, Y; Uehira, T; Yamazaki, K | 1 |
| Bosman, N; Chibabhai, V; Lowman, W; Nana, T; Thomas, T | 1 |
| Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D | 1 |
| Bush, K; Kashikar, A; Zhang, Y | 1 |
| Campos, S; González-Castro, A; Pérez Canga, JL; Rodríguez-Borregán, JC | 1 |
| Béchet, S; Biscardi, S; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; Dubos, F; Galerne, A; Grimprel, E; Hees, L; Hentgen, V; Jung, C; Levy, C; Lorrot, M; Madhi, F; Timsit, S | 1 |
| Barber, KE; Bonomo, RA; Kaye, KS; Pogue, JM; Warnock, HD | 1 |
| Burgess, DS; Campion, JJ; Feola, DJ; Kulengowski, B; Lee, GC; Rutter, WC | 1 |
| Bueno, MFC; Camargo, CH; Cury, AP; David-Neto, E; de Oliveira Garcia, D; de Paula, FJ; Dos Santos, NF; Francisco, GR; Freire, MP; Nahas, WC; Pierrotti, LC; Rossi, F; Spadão, F | 1 |
| Douthwaite, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; Hopkins, KL; Ovejero, CM; Prasad, KN; Shukla, S; Woodford, N | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 1 |
| Athanasiou, S; Falagas, ME; Tansarli, GS | 1 |
| Daikos, GL; Flountzi, A; Giannopoulou, M; Goukos, D; Kosmidis, C; Markogiannakis, A; Petrikkos, G; Tzanetou, K | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Barberi, G; Cascio, A; Di Bernardo, F; Giordano, S; Iaria, C; Mezzatesta, ML; Odierna, A; Stefani, S | 1 |
| Antonopoulos, IM; David-Neto, E; de Paula, FJ; Freire, MP; Guimarães, T; Moura, ML; Nahas, WC; Pierrotti, LC; Piovesan, AC; Spadão, F | 1 |
| Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Gil-Romero, Y; Gómez-Garcés, JL; Merino, F; Vazquez, O | 1 |
| Boix, V; Coy, J; Garcinuño, P; Gimeno, L; Merino, E; Portilla, J; Rodríguez, JC; Sánchez-Bautista, A; Sánchez-Paya, J; Santibañez, M | 1 |
| Costa, SF; de Castro Lima, VA; de Maio Carrillho, CM; de Oliveira, LM; Gaudereto, JJ; Levin, AS; Martins, RC; Perozin, JS; Urbano, MR | 1 |
| Akhi, MT; Asgharzadeh, M; Ghotaslou, R; Mohammadzadeh Asl, Y; Yeganeh Sefidan, F | 1 |
| Dalamaga, M; Daskalopoulou, K; Karmaniolas, K; Pantelaki, M; Papadavid, E | 1 |
| Cho, DT; Kang, HY; Kim, J; Lee, JC; Lee, YC; Seol, SY | 1 |
| Chen, KJ; Sun, CC; Yang, KJ; Yeung, L | 1 |
| Bautista, V; Campos, J; Fernández, S; Gil-Antón, J; Hernández-Almaraz, JL; Oteo, J; Vindel, A | 1 |
| Boileau, P; Coquery, S; Guibert, M; Traoré, P; Zupan-Simunek, V | 1 |
| Kim, SY; Kim, YS; Park, YJ; Yu, JK | 1 |
| Bernusset, S; Cattoen, C; Cuzon, G; Naas, T; Nordmann, P | 1 |
| Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG | 1 |
| Kimura, S; Kitazawa, T; Koga, I; Makita, E; Matsunaga, N; Okugawa, S; Ota, Y; Seo, K; Yoshino, Y | 1 |
| Argyropoulou, A; Chrysouli, Z; Daikos, GL; Galani, I; Giamarellou, H; Panagea, T; Petrikkos, G; Plakias, G; Poulakou, G; Psichogiou, M; Souli, M; Stefanou, I | 1 |
| Cassady, G; Dworsky, ME; Philips, JB; Satterwhite, C | 1 |
| Kontos, V; Papadogiannakis, E; Perimeni, D; Vatopoulos, A; Velonakis, E | 1 |
| Adamski, R; Jankowski, S; Kłak, M; Wojnicz, D | 1 |
| Cho, DT; Kang, HY; Kim, J; Kim, KY; Lee, JC; Lee, YC; Seol, SY | 1 |
| Bryskier, A; Husson, MO; Izard, D; Leclerc, H; Vincent, P | 1 |
| Barriere, SL; Pons, VG; Wilson, CB | 1 |
| Fleming, PJ; Hawkey, PM; Lewis, DA; Pitt, TL; Primavesi, RJ; Speller, DC | 1 |
| Holloway, WJ; Reinhardt, JF | 1 |
| Baker, CJ; Faingezicht, I; Feldman, WE; Kaplan, SL; McCracken, GH; Mize, S; Schaad, U; Threlkeld, N | 1 |
| Barnes, RC; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
| Greene, GR; Heitlinger, L; Madden, JD | 1 |
| Kawabata, S; Nishino, T; Tanaka, M; Tanino, T | 1 |
| Betts, RF; Chapman, SW; Chonmaitree, T; Messner, M; Mowrer, G; Pincus, P; Robertson, R; Valenti, WM | 1 |
| Ehrensaft, DV; Safani, MM | 1 |
| Gruensfelder, R; Kabins, SA; Nathan, C; Weinstein, RA | 1 |
| Cook, LN; Davis, RS; Stover, BH | 1 |
| Gammon, JA; Joseph, P; Schwab, I | 1 |
| Bis, W; Jeljaszewicz, J; Kazanowski, A; Kuzniewski, P; Molska, J; Włodarczak, K | 1 |
| de la Serna, JL; de Villota, ED; Diez-Balda, V; Galdos, P; Mosquera, JM; Rubio, JJ; Tomás, MI | 1 |
| Adams, HG; Barriere, SL; Honda, DH | 1 |
| Canafax, DM; Peterson, PK; Simmons, RL; Tofte, RW | 1 |
| Jones, RN; Packer, RR | 1 |
| Roy, I; Thadepalli, H | 1 |
| de Champs, C; Franchineau, P; Gaulme, J; Gourgand, JM; Loriette, Y; Sirot, J | 1 |
| Balslev, T; Ebbesen, F; Korsager, B; Kristensen, B; Schumacher, H | 1 |
| Caillon, J; Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
| Bramlage, LR; Embertson, RM; Holcombe, SJ; Schneider, RK | 1 |
| Jacolot, A; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
| Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
| Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
| Bibashi, E; Kati, C; Kokolina, E; Sofianou, D | 1 |
| Berger, R; Gruenewald, T; Leibovici, L; Milo, G; Paul, M; Pitlik, SD; Samra, Z; Yahav, J; Yehezkelli, Y | 1 |
| Halter, J; Lewis, RP; Meyer, RD; White, M | 1 |
| Blech, MF; Hartemann, P; Imbs, MA | 1 |
| Craven, PC; Drutz, DJ; Jorgensen, JH; Kaspar, RL | 1 |
| De Kock, MA; Theron, FP | 1 |
| Greenman, RL; Hoffman, TA; Sklaver, AR | 1 |
| McGee, ZA; Meacham, WF; Oldfield, EH; Wirt, TC | 1 |
| Aguirre, M; Ales, JM; Torres, A | 1 |
| Alford, RH; Leonard, JM; McGee, ZA | 1 |
| Berger, SA; Pollock, AA; Rahal, JJ; Richmond, AS; Simberkoff, MS | 1 |
| Long, CI; Vannatta, JB | 1 |
| Chapman, MW; Donovan, TL; Harrington, KD; Nagel, DA | 1 |
| Cox, CE | 1 |
| Hensgens, C; Klastersky, J; Meunier-Carpentier, F | 1 |
| Agre, K; Berman, E; Gooding, PG; Lane, AZ | 1 |
| Grunert, K; Koeppe, P; Langmaack, H; Lode, H | 1 |
| Berger, J; Cates, CY; Fox, LM; Gurwith, MJ; Lank, BA; Mathias, RG; McCullough, DW; Ronald, AR; Stiver, HG | 1 |
| Marget, W; Reindke, B; Versmold, H | 1 |
| Yow, MD | 1 |
| Dzierzanowska, D | 1 |
| Brumfitt, W; Daikos, GK; Hamilton-Miller, JM; Kosmidis, JC | 1 |
| Becerra-Munoz, E; Bravo-Scandoval, J; Cinco-Espinoza, G; Flores-Mercado, F; Galindo-Hernandez, E; Ramirez-Jiménez, D | 1 |
| Mazzei, T; Nicoletti, I; Paradiso, M; Periti, P | 1 |
| Dámaso, D; García-Iglesias, MC; Martínez-Beltrán, J; Moreno-López, M | 1 |
| Agudelo, N; De Vidal, EL; Londono, R; Manotas, R; Ramirez, JI; Trujillo, H; Uribe, A | 1 |
| Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
| Bartlett, JG; Gorbach, SL; Louie, TJ; O'Keefe, P; Tally, FP | 1 |
| Agudelo, NH; de Vidal, EL; Ramirez, JI; Trujillo, H; Uribe, A | 1 |
| Kluyskens, P; Pauwels, R; Pijck, J; Soep, H; Van Der Straeten, M; Van Nimmen, L | 1 |
| Lüthy, R | 1 |
| Bartlett, JG; Gorbach, SL; Louie, TJ; Tally, FP; Weinstein, WM | 1 |
| Anisimova, LA; Boronin, AM; Erova, TE; Moreva, TV | 1 |
| Ba, M; Cissé, MF; Ouangre, AR; Samb, A; Sow, AI | 1 |
| del Pilar Pla, M; Flores, A; Hopkins, JD; Lester, S; O'Brien, TF | 1 |
| Craig, WA; Ebert, SC; Redington, J | 1 |
| Espinal, D; Garces, G; Mejia de Rodriguez, GI; Mejia, J; Restrepo, C; Restrepo, F; Robledo, C; Robledo, J; Tamayo de Guitierrez, MC; Trujillo, H | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Fantin, B; Le Conte, P; Le Gallou, F; Lepage, JY; Potel, G; Raza, J | 1 |
| Zhang, YP | 1 |
| Benson, CE; Orsini, JA; Spencer, PA; Van Miller, E | 1 |
| Acar, JF; Collatz, E; Goldstein, FW; Pinto, ME; Van Nhieu, GT | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Mayer, KH | 1 |
| Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Auboyer, C; Becq-Giraudon, B; Bertrand, P; Buré, A; Carbon, C; Gallais, H; Motin, JP; Mouton, Y; Vachon, F; Wasmer, JM | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
| King, A; Phillips, I; Shannon, K | 1 |
| Bouanchaud, DH; Rolin, O | 1 |
| Hanna, BA; Leibowitz, RE; Levine, JF; Maslow, MJ; Pollock, AA; Rahal, JJ; Schaefler, S; Simberkoff, MS | 1 |
| Maslow, MJ; Rahal, JJ; Simberkoff, MS | 1 |
6 review(s) available for amikacin and Cronobacter Infections
| Article | Year |
|---|---|
Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Biological Availability; Carbapenem-Resistant Enterobacteriaceae; Cell Membrane Permeability; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Protein Biosynthesis | 2017 |
Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Child; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Meropenem; Serratia Infections; Serratia marcescens; Thienamycins; Treatment Outcome | 2018 |
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.
Topics: Africa; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Databases, Factual; Drug Evaluation; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2013 |
[Serratia, cause of nosocomial infections and its occurrence in the patient's environment (author's transl)].
Topics: Air Microbiology; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Epidemiologic Methods; Erythromycin; Gentamicins; Humans; Lincomycin; Polymyxins; Serratia marcescens; Sisomicin; Soil Microbiology; Tetracyclines; Tobramycin; Water Microbiology | 1979 |
[Aminoglycoside antibiotics from clinical viewpoint].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Glomerular Filtration Rate; Kanamycin; Klebsiella Infections; Proteus Infections; Providencia; Pseudomonas Infections; Serratia; Sisomicin; Streptomycin; Tobramycin | 1975 |
Review of epidemic aminoglycoside resistance worldwide.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Gentamicins; Humans; Klebsiella; Pseudomonas aeruginosa; R Factors; Tobramycin | 1986 |
9 trial(s) available for amikacin and Cronobacter Infections
| Article | Year |
|---|---|
Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation.
Topics: Amikacin; Ampicillin; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Infant, Newborn; Meningitis; Moxalactam; Prospective Studies; Radiography | 1984 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Imipenem; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1997 |
[The antibiotic amikacin in various types of infections].
Topics: Adolescent; Adult; Aged; Amikacin; Child; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged | 1979 |
Amikacin Therapy of Urinary tract infections.
Topics: Adolescent; Adult; Aged; Amikacin; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial.
Topics: Amikacin; Bacterial Infections; Blood Bactericidal Activity; Carbenicillin; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Penicillin G; Pseudomonas Infections; Sepsis | 1976 |
A review of results of clinical trials with amikacin.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Bone Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1976 |
Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
Topics: Aged; Amikacin; Clinical Trials as Topic; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Pseudomonas; Pseudomonas Infections | 1975 |
Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.
Topics: Amikacin; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis | 1987 |
118 other study(ies) available for amikacin and Cronobacter Infections
| Article | Year |
|---|---|
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Latin America; Microbial Sensitivity Tests; Minocycline; North America; Population Surveillance; Tigecycline | 2008 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence | 2010 |
Clinical and microbiological characteristics of carbapenem-resistant Enterobacteriaceae causing post-operative central nervous system infections in China.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Central Nervous System Infections; Enterobacteriaceae Infections; Humans; Multilocus Sequence Typing | 2023 |
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial R
Topics: Amikacin; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pacific Islands; Population Surveillance | 2020 |
Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Genome, Bacterial; Genomics; Humans; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Phylogeny; Plasmids; South Africa; Urinary Tract Infections | 2020 |
Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant
Topics: Amikacin; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2019 |
First isolation of Klebsiella variicola from a horse pleural effusion.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Enterobacteriaceae Infections; Horse Diseases; Horses; Klebsiella; Male; Microbial Sensitivity Tests; Oxytetracycline; Pleural Effusion; Pulmonary Atelectasis | 2021 |
A new emerging oral infection: Raoultella planticola in a boy with haematological malignancy.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Burkitt Lymphoma; Ceftazidime; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Stomatitis | 2017 |
IMP-6 Carbapenemase-Producing Enterobacteriaceae Bacteremia Successfully Treated with Amikacin-Meropenem in Two Patients.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Treatment Outcome | 2017 |
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazoba
Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins | 2018 |
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Indiana; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Sisomicin | 2017 |
Catheter-related bacteraemia caused by Raoultella ornithinolytica.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Catheter-Related Infections; Cefepime; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Female; Humans; Pancreatic Neoplasms; Postoperative Complications | 2018 |
Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fever; France; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prospective Studies; Risk Factors; Urinary Tract Infections | 2018 |
Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Drug Combinations; Enterobacteriaceae Infections; Meropenem; Models, Theoretical; Polymyxin B; Treatment Outcome | 2018 |
Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL- and KPC-producing Enterobacter cloacae.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cytoskeletal Proteins; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Multilocus Sequence Typing; Polymyxin B | 2018 |
The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Fosfomycin; Humans; Kidney Transplantation; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxins; Retrospective Studies; Risk Factors; Transplant Recipients; Treatment Failure; Treatment Outcome | 2019 |
Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK.
Topics: Amikacin; Aminoglycosides; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; India; Methyltransferases; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; United Kingdom | 2013 |
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections | 2013 |
Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Gentamicins; Greece; Humans; Microbial Sensitivity Tests; Practice Patterns, Physicians' | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin.
Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cerebral Ventriculitis; Child, Preschool; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Teicoplanin; Treatment Outcome | 2014 |
Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; beta-Lactamases; Cephalosporins; Child; Cohort Studies; Delayed Graft Function; Enterobacteriaceae Infections; Female; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Risk Factors; Surgical Wound Infection; Time Factors; Tissue Donors; Treatment Outcome; Young Adult | 2015 |
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
[Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colonic Diseases; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Hernia, Abdominal; Herniorrhaphy; Humans; Intestinal Fistula; Minocycline; Postoperative Complications; Prosthesis-Related Infections; Soft Tissue Infections; Surgical Mesh; Tigecycline | 2017 |
Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Spain; Thienamycins | 2016 |
Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia; Prospective Studies; Soft Tissue Infections; Tigecycline; Urinary Tract Infections | 2017 |
Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Genes, Bacterial; Gentamicins; Hospitals; Humans; Iran; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Sequence Analysis, DNA; Streptomycin; Tobramycin | 2017 |
[Epididymo-orchitis and bacteremia caused by Leclercia adecarboxylata].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Epididymitis; Humans; Male; Microbial Sensitivity Tests; Opportunistic Infections; Orchitis; Paraplegia | 2008 |
Characterization of conjugative plasmids carrying antibiotic resistance genes encoding 16S rRNA methylase, extended-spectrum beta-lactamase, and/or plasmid-mediated AmpC beta-lactamase.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Gene Transfer, Horizontal; Gentamicins; Humans; Kanamycin; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymorphism, Restriction Fragment Length; Tobramycin | 2009 |
Traumatic endophthalmitis caused by Enterococcus raffinosus and Enterobacter gergoviae.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Endophthalmitis; Enterobacter; Enterobacteriaceae Infections; Enterococcus; Eye Injuries, Penetrating; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin; Wound Infection | 2009 |
Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Child; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Infant; Integrons; Intensive Care Units, Pediatric; Male; Plasmids; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
[Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Treatment Outcome | 2010 |
Aminoglycoside susceptibility profiles of Enterobacter cloacae isolates harboring the aac(6')-Ib gene.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France.
Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; France; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam | 2012 |
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2012 |
Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Endocarditis; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Meropenem; Thienamycins; Treatment Outcome | 2015 |
Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sisomicin; Tertiary Care Centers; Tobramycin | 2012 |
Recommended amikacin doses in newborns often produce excessive serum levels.
Topics: Amikacin; Birth Weight; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Health Planning Guidelines; Humans; Infant, Newborn; Male | 1982 |
Providencia stuartii infection in a dog with severe skin ulceration and cellulitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cellulitis; Diagnosis, Differential; Dog Diseases; Dogs; Enterobacteriaceae Infections; Female; Providencia; Skin Ulcer; Treatment Outcome | 2007 |
Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains.
Topics: Amikacin; Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Epithelial Cells; Female; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Phase-Contrast; Urinary Tract Infections | 2007 |
Distribution of conjugative-plasmid-mediated 16S rRNA methylase genes among amikacin-resistant Enterobacteriaceae isolates collected in 1995 to 1998 and 2001 to 2006 at a university hospital in South Korea and identification of conjugative plasmids mediat
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Hospitals, University; Humans; Korea; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2008 |
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Netilmicin; Species Specificity; Tobramycin | 1984 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Amikacin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam | 1982 |
Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Topics: Acetyltransferases; Amikacin; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Netilmicin; Nurseries, Hospital; Serratia marcescens; Tobramycin | 1983 |
Serratia marcescens pyarthrosis and osteomyelitis.
Topics: Adult; Amikacin; Amphetamine; Arthritis, Infectious; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Male; Moxalactam; Osteomyelitis; Serratia marcescens; Substance-Related Disorders; Suppuration | 1984 |
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacteria, Anaerobic; Bacterial Infections; Child; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Fever; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Piperacillin; Pseudomonas Infections; Random Allocation; Staphylococcal Infections | 1984 |
Citrobacter ventriculitis in a neonate responsive to trimethoprim-sulfamethoxazole.
Topics: Amikacin; Cerebral Ventricles; Citrobacter; Drug Combinations; Encephalitis; Enterobacteriaceae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Meningitis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
[Combined action of cephamycin and aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Animals; Bacteria; Cefoxitin; Dibekacin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Kanamycin; Male; Mice | 1983 |
Five-year surveillance of aminoglycoside usage in a university hospital.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterobacteriaceae Infections; Gentamicins; Hospitals, University; Humans; Middle Aged; New York; Prospective Studies; Pseudomonas Infections | 1984 |
Successful treatment of subdural empyema due to Serratia marcescens.
Topics: Aged; Amikacin; Brain Abscess; Enterobacteriaceae Infections; Humans; Male; Serratia marcescens; Therapeutic Irrigation; Ticarcillin | 1982 |
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.
Topics: Amikacin; Aminoglycosides; Chicago; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gentamicins; Gram-Negative Aerobic Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Netilmicin; Pseudomonadaceae; Pseudomonas aeruginosa; Tobramycin; Urine | 1980 |
Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
Topics: Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Netilmicin; Nurseries, Hospital; Serratia marcescens; Sisomicin | 1980 |
Gentamicin-resistant Serratia marcescens endophthalmitis.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Drug Resistance, Microbial; Endophthalmitis; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Middle Aged; Serratia marcescens; Tobramycin | 1980 |
Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
Topics: Amikacin; Animals; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Rabbits; Sisomicin | 1980 |
Amikacin treatment of Serratia septicemia in critically ill patients.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Critical Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Sepsis; Serratia marcescens | 1981 |
Amikacin penetration into synovial fluid during treatment of septic arthritis.
Topics: Aged; Amikacin; Arthritis, Infectious; Enterobacteriaceae Infections; Humans; Kanamycin; Male; Serratia marcescens; Synovial Fluid | 1981 |
Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.
Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Kidney Transplantation; Labyrinth Diseases; Male; Middle Aged; Pseudomonas Infections | 1982 |
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.
Topics: Amikacin; Cephalosporins; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests | 1982 |
Netilmicin: its in vitro activity and synergism with penicillin compounds.
Topics: Amikacin; Bacteria; Drug Synergism; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Netilmicin; Penicillins; Pseudomonas Infections; Sisomicin; Tobramycin | 1980 |
Clinical and bacteriological survey after change in aminoglycoside treatment to control an epidemic of Enterobacter cloacae.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; France; Gentamicins; Humans; Infant, Newborn; Intensive Care Units, Neonatal | 1994 |
Gentamicin-resistant Enterobacteriaceae in a neonatal intensive care unit.
Topics: Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Hygiene; Infant, Newborn; Intensive Care Units, Neonatal | 1993 |
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Kidney; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Wistar | 1997 |
Use of antibiotic-impregnated polymethyl methacrylate in horses with open or infected fractures or joints: 19 cases (1987-1995).
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefazolin; Combined Modality Therapy; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fracture Fixation, Internal; Fractures, Open; Gentamicins; Horse Diseases; Horses; Joint Diseases; Joints; Osteomyelitis; Polymethyl Methacrylate; Retrospective Studies; Synovitis; Tobramycin | 1997 |
Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Creatinine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Mutant Strains; Time Factors; Treatment Outcome | 1998 |
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins | 1998 |
Case of peritonitis caused by Ewingella americana in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1999 |
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Internal Medicine; Logistic Models | 2001 |
Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
Topics: Amikacin; Aminoglycosides; California; Carbenicillin; Cross Infection; Enterobacteriaceae Infections; Gentamicins; Hospitals, General; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Sisomicin; Tobramycin | 1976 |
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
Topics: Adult; Aged; Amikacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Serratia marcescens; Urinary Tract Infections | 1977 |
Clinical experience with amikacin, a new aminoglycoside antibiotic.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Male; Middle Aged; Pseudomonas Infections | 1977 |
Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Kanamycin; Klebsiella Infections; Meningitis; Proteus Infections; Sepsis; Serratia marcescens | 1978 |
Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
Topics: Acinetobacter Infections; Amikacin; Child, Preschool; Encephalitis; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Injections, Intraventricular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Serratia marcescens | 1979 |
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections | 1978 |
Amikacin therapy for serious gram-negative infection.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Kanamycin; Kidney; Klebsiella Infections; Middle Aged; Pseudomonas Infections; Sepsis | 1977 |
Antibiotic-associated colitis: report of a case.
Topics: Amikacin; Enterobacteriaceae Infections; Enterocolitis, Pseudomembranous; Humans; Injections, Intraperitoneal; Kanamycin; Male; Middle Aged; Peritonitis; Vancomycin | 1978 |
Serratia arthritis. Report of seven cases.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Arthritis, Infectious; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Serratia marcescens; Substance-Related Disorders | 1976 |
Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Bronchitis; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
Use of Amikacin in a hospital for children: microbiological and clinical studies.
Topics: Amikacin; Aminoglycosides; Bacterial Infections; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Kanamycin; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections | 1976 |
An overview of pediatric experience with amikacin.
Topics: Amikacin; Bacterial Infections; Child; Cross Infection; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin | 1977 |
[New aminoglycoside antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Kanamycin; Pseudomonas Infections; Tobramycin | 1977 |
Amikacin in treatment of infections caused by gram-negative bacteria resistant to gentamicin and other aminoglycosides: clinical and bacteriologic results.
Topics: Adolescent; Adult; Aged; Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kanamycin; Male; Micrococcus; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1976 |
Amikacin for treatment of septic abortions: summary.
Topics: Abortion, Septic; Amikacin; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Pregnancy; Sepsis | 1976 |
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fetal Blood; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Kidney Failure, Chronic; Pregnancy; Pregnancy Complications, Infectious; Pseudomonas Infections; Urinary Tract Infections | 1976 |
Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Chronic Disease; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1976 |
Clinical and laboratory studies with amikacin in newborns, infants, and children.
Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kanamycin; Male; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections | 1976 |
Amikacin for treatment of infections in patients with malignant diseases.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Blood Cell Count; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Neutrophils; Pseudomonas Infections | 1976 |
Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
Topics: Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections; Sepsis | 1976 |
Amikacin (BBK8) in infections due to gram-negative organisms in children over the age of one month.
Topics: Adolescent; Amikacin; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Enterobacteriaceae Infections; Female; Humans; Infant; Injections, Intramuscular; Kanamycin; Male; Microbial Sensitivity Tests; Pseudomonas Infections | 1976 |
Amikacin in the treatment of gram-negative bronchopulmonary infections.
Topics: Acute Disease; Adult; Aged; Amikacin; Enterobacteriaceae Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Kanamycin; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections | 1976 |
[Amikacin resistance of clinical strains of Enterobacteriaceae and Pseudomonas].
Topics: Amikacin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors | 1992 |
[Bacteriology of neonatal septicemia in Dakar].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Incidence; Infant, Newborn; Klebsiella Infections; Male; Senegal; Staphylococcal Infections; Streptococcal Infections | 1992 |
Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid.
Topics: Alleles; Amikacin; Conjugation, Genetic; Cross Infection; DNA Transposable Elements; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Operon; Plasmids | 1991 |
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections.
Topics: Amikacin; Animals; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Kidney; Klebsiella pneumoniae; Lung Diseases; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Specific Pathogen-Free Organisms; Thigh | 1991 |
Single daily dose amikacin in paediatric patients with severe gram-negative infections.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Lactams; Prospective Studies; Pseudomonas Infections | 1991 |
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
Topics: Amikacin; Animals; Drug Administration Schedule; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Rabbits; Serratia marcescens; Tobramycin | 1991 |
[Opportunistic infection and systemic dissemination in burns].
Topics: Amikacin; Burns; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia | 1989 |
Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
Topics: Amikacin; Animals; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gentamicins; Horse Diseases; Horses; Klebsiella; Microbial Sensitivity Tests; Proteus; Pseudomonas; Pseudomonas Infections | 1989 |
Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile.
Topics: Amikacin; Aminoglycosides; Chile; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Plasmids | 1986 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits | 1986 |
Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae.
Topics: Amikacin; Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia marcescens | 1987 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |
Prevalence and mechanisms of aminoglycoside resistance. A ten-year study.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus aureus; Tobramycin | 1986 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.
Topics: Acetyltransferases; Amikacin; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Kanamycin; New York; Pseudomonas aeruginosa; Pseudomonas Infections; R Factors | 1985 |
Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Topics: Aged; Amikacin; Aminoglycosides; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens | 1985 |